REG - Induction Healthcare - Block Listing Six Monthly Return

Induction HealthcareAnnouncement

27/07/2022 10:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220727:nRSa9203Ta&default-theme=true

RNS Number : 9203T  Induction Healthcare Group PLC   27 July 2022

 

Induction Healthcare Group PLC

("Induction", the "Company", or the "Group")

 

Block Listing Six Monthly Return

 

Induction Healthcare (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, makes the following six
monthly update on its block listing pursuant to AIM Rule 29 and Schedule 6 of
the AIM Rules for Companies:

 

 Name of applicant:                                                                Induction Healthcare Group PLC

                                                                                   LEI: 213800RY96GCZQW5TP19

 Name of scheme:                                                                   The Induction Healthcare NTA Share Option Plan

 Period of return:                                                                  From:        26/01/2022    To:           26/07/2022

 Number and class of securities originally admitted and the date of admission      3,500,000 ordinary shares on 26 July 2021

 Balance of unallotted securities under scheme(s) from initial application:        3,500,000

 Plus: The amount by which the block scheme(s) has been increased since the        nil
 date of the last return (if any increase has been applied for):

 Less: Number of securities issued/allotted under scheme(s) during the period:     396,567

 Equals: Balance under scheme(s) not yet issued/allotted at end of period:         3,103,433

 Contact:                                                                          Alison Talbot, Company Secretary

                                                                                   +44 (0) 3339 398 091

 

ENQUIRIES

 

 Induction                                              Via Walbrook PR Ltd: induction@walbrookpr.com

 James Balmain, Chief Executive Officer

 Guy Mitchell, Chief Financial Officer

 Singer Capital Markets (Nominated Adviser and Broker)  +44 (0) 20 7496 3000
 Philip Davies / Kailey Aliyar

 Walbrook PR Ltd                                        induction@walbrookpr.com
 Paul McManus / Alice Woodings                          Mob: +44(0)7980 541 893 / +44 (0)7407 804 654

 

 

 

About Induction - www.inductionhealthcare.com
(http://www.inductionhealthcare.com)

 

Induction (AIM: INHC) Induction delivers a suite of software solutions through
a single integrated platform that transforms care delivery. Our system-wide
applications help healthcare providers and administrators to deliver care at
any stage remotely as well as face-to-face - giving the communities they serve
greater flexibility, control and ease of access. Purpose-built for integration
with leading Electronic Medical Record (EMR) platforms, our products offer
immediate stand-alone value that becomes even greater when integrated with
pre-existing systems.

 

Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BLRSEESUWEESESW